ESCMID: ESGAI

Aims and objectives

The ESCMID Study Group for Anaerobic Infections (ESGAI) is at the forefront of advancing research and knowledge on anaerobic pathogens. Bringing together an international community of experts, ESGAI is committed to:

Performing innovative fundamental and clinical research to better understand the pathogenicity, clinical manifestations, and antibiotic resistance mechanisms of anaerobic pathogens
Providing clinicians with crucial information and updates on diagnosing anaerobic pathogens
Supporting early-career scientists and clinicians in their research on anaerobic pathogens
Organising conferences and educational workshops to foster knowledge sharing
Cultivating a vibrant and engaging community
Sharing knowledge with the general public

Activities and resources

ESGAI Newsletter, April 2024

Download

Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag)

Buhl MEJ, Sunnerhagen T, Join-Lambert O, Morris T, Jeverica S, Assous MV, Toprak NU, Alcalá-Hernandez L, Lienhard R, Veloo ACM, Cruz H, Sóki J, Novak A, Mazzariol A, Wybo I, Dumont Y, Justesen US; ReSuBacfrag Study Group; ESGAI. Int J Antimicrob Agents. 2024 Sep;64(3):107241

Go to publication

Molecular characterization and antibiotic resistance of clinical Bacteroides and related genera from a tertiary care center in Türkiye

Demir M, Soki J, Tanrıverdi ES, Özkul C, Mahmood B, Otlu B, Hazırolan G; ESCMID Study Group for Anaerobic Infections (ESGAI). Anaerobe. 2024 Sep 24;90:102912

Go to publication